Su Qiu

5.8k citations

38 papers · 4.2k indexed · 2 hit papers · h-index 29

Co-authors: Shaomeng Wang Zaneta Nikolovska‐Coleska Chao‐Yie Yang Jeanne A. Stuckey Junya Masumoto Naohiro Inohara Gabriel Núñez Haiying Sun
Topics: Cell death mechanisms and regulation (19 papers)ATP Synthase and ATPases Research (11 papers)Ubiquitin and proteasome pathways (7 papers)
Cited by: Immunology Toxicology Microbiology
Journals: Journal of the American Chemical Society Nature Communications The Journal of Experimental Medicine
Partner nations: United States China Japan

In The Last Decade

Su Qiu

38 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

2003 1.0k citations Mathias Chamaillard, Masahito Hashimoto et al. Nature Immunology profile →
Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors

2005 564 citations Ke Ding, Yipin Lu et al. profile →

Peers

Countries citing papers authored by Su Qiu

Since Specialization

Citations

This map shows the geographic impact of Su Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Qiu more than expected).

Fields of papers citing papers by Su Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Qiu. The network helps show where Su Qiu may publish in the future.

Co-authorship network of co-authors of Su Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Su Qiu. A scholar is included among the top collaborators of Su Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Qiu. Su Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils 2025 ·Nature Communications ·Xiaocheng Wang,Maosheng Cheng,Shuang Chen,Caihua Zhang,Rongsong Ling,Su Qiu,Ke Chen,Bin Zhou,(unknown),Wenbin Lei,Demeng Chen	1
2	Unique Mechanism of the Interaction between Honey Bee Toxin TPNQ and rKir1.1 Potassium Channel Explored by Computational Simulations: Insights into the Relative Insensitivity of Channel towards Animal Toxins 2013 ·PLoS ONE ·Jun Hu,Su Qiu,Fan Yang,Zhijian Cao,Wenxin Li,Yingliang Wu	7
3	Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment 2011 ·Molecular Cancer Therapeutics ·Jianfeng Lü,Donna McEachern,Haiying Sun,Longchuan Bai,Yuefeng Peng,Su Qiu,Rebecca S. Miller,Jinhui Liao,Yi Han,Meilan Liu,Anita C. Bellail,Chunhai Hao,Shi-Yong Sun,Adrian T. Ting,Shaomeng Wang	51
4	A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment 2011 ·Journal of Medicinal Chemistry ·Qian Cai,Haiying Sun,Yuefeng Peng,Jianfeng Lü,Zaneta Nikolovska‐Coleska,Donna McEachern,Liu Liu,Su Qiu,Chao‐Yie Yang,Rebecca S. Miller,Yi Han,Tao Zhang,Duxin Sun,Sunghyun Kang,Ming Guo,Lance Leopold,Dajun Yang,Shaomeng Wang	213
5	SdPI, The First Functionally Characterized Kunitz-Type Trypsin Inhibitor from Scorpion Venom 2011 ·PLoS ONE ·Ruiming Zhao,Hui Dai,Su Qiu,Tian Li,Yawen He,Yibao Ma,Zongyun Chen,Yingliang Wu,Wenxin Li,Zhijian Cao	55
6	Potent Bivalent Smac Mimetics: Effect of the Linker on Binding to Inhibitor of Apoptosis Proteins (IAPs) and Anticancer Activity 2011 ·Journal of Medicinal Chemistry ·Haiying Sun,Liu Liu,Jianfeng Lü,Longchuan Bai,Xiaoqin Li,Zaneta Nikolovska‐Coleska,Donna McEachern,Chao‐Yie Yang,Su Qiu,Yi Han,Duxin Sun,Shaomeng Wang	31
7	Cyclopeptide Smac mimetics as antagonists of IAP proteins 2010 ·Bioorganic & Medicinal Chemistry Letters ·Haiying Sun,Liu Liu,Jianfeng Lü,Su Qiu,Chao‐Yie Yang,Yi Han,Shaomeng Wang	28
8	Effect of (-)-gossypol (AT-101) on transcriptional regulation of Noxa and Puma and on Mcl-1-mediated cancer cell resistance to apoptosis 2009 ·Journal of Clinical Oncology ·(unknown),(unknown),Longchuan Bai,Jianting Long,Su Qiu,J. Chen,Donna McEachern	2
9	Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer 2008 ·Molecular Cancer Therapeutics ·Sanjeev Shangary,Ke Ding,Su Qiu,Zaneta Nikolovska‐Coleska,Joshua A. Bauer,Meilan Liu,Guoping Wang,Yipin Lu,Donna McEachern,Denzil Bernard,Carol R. Bradford,Thomas E. Carey,Shaomeng Wang	75
10	SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP 2008 ·Cancer Research ·Jianfeng Lü,Longchuan Bai,Haiying Sun,Zaneta Nikolovska‐Coleska,Donna McEachern,Su Qiu,Rebecca S. Miller,Yi Han,Sanjeev Shangary,Yi Sun,Jennifer L. Meagher,Jeanne A. Stuckey,Shaomeng Wang	174
11	Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP) 2008 ·Journal of Medicinal Chemistry ·Haiying Sun,Jeanne A. Stuckey,Zaneta Nikolovska‐Coleska,Dongguang Qin,Jennifer L. Meagher,Su Qiu,Jianfeng Lü,Chao‐Yie Yang,Naoyuki G. Saito,Shaomeng Wang	69
12	Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics 2008 ·Accounts of Chemical Research ·Haiying Sun,Zaneta Nikolovska‐Coleska,Chao‐Yie Yang,(unknown),Jianfeng Lü,Su Qiu,Longchuan Bai,Yuefeng Peng,Qian Cai,Shaomeng Wang	132
13	Design, Synthesis, and Evaluation of Tricyclic, Conformationally Constrained Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases 2008 ·Journal of Medicinal Chemistry ·Bin Zhang,Zaneta Nikolovska‐Coleska,Yan Zhang,Longchuan Bai,Su Qiu,Chao‐Yie Yang,Haiying Sun,Shaomeng Wang,Yikang Wu	27
14	Pyrogallol-Based Molecules as Potent Inhibitors of the Antiapoptotic Bcl-2 Proteins 2007 ·Journal of Medicinal Chemistry ·Guozhi Tang,Chao‐Yie Yang,Zaneta Nikolovska‐Coleska,Jie Guo,Su Qiu,Renxiao Wang,Wei Gao,Guoping Wang,Jeanne A. Stuckey,Krzysztof Krajewski,Sheng Jiang,Peter P. Roller,Shaomeng Wang	42
15	Molecular basis of inhibitory peptide maurotoxin recognizing Kv1.2 channel explored by ZDOCK and molecular dynamic simulations 2007 ·Proteins Structure Function and Bioinformatics ·Hong Yi,Su Qiu,Zhijian Cao,Yingliang Wu,Wenxin Li	47
16	Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo 2006 ·The Journal of Experimental Medicine ·Junya Masumoto,Kangkang Yang,Sooryanarayana Varambally,Mizuho Hasegawa,Scott A. Tomlins,Su Qiu,Yukari Fujimoto,Akiko Kawasaki,Simon J. Foster,Yasuo Horie,Tak W. Mak,Gabriel Núñez,Arul M. Chinnaiyan,Koichi Fukase,Naohiro Inohara	176
17	Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jianyong Chen,Zaneta Nikolovska‐Coleska,Guoping Wang,Su Qiu,Shaomeng Wang	63
18	Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo 2006 ·The Journal of Cell Biology ·Junya Masumoto,Kangkang Yang,Sooryanarayana Varambally,Mizuho Hasegawa,Scott A. Tomlins,Su Qiu,Yukari Fujimoto,Akiko Kawasaki,Simon J. Foster,Yasuo Horie,Tak W. Mak,Gabriel Núñez,Arul M. Chinnaiyan,Koichi Fukase,Naohiro Inohara	7
19	Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition 2004 ·The EMBO Journal ·Tsuyoshi Tanabe,Mathias Chamaillard,Yasunori Ogura,Zhu Li,Su Qiu,Junya Masumoto,Partho Ghosh,Anthony P. Moran,(unknown),Gerard Tromp,Charlene J. Williams,Naohiro Inohara,Gabriel Núñez	293
20	An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acidbreakdown → 2003 ·Nature Immunology ·Mathias Chamaillard,Masahito Hashimoto,Yasuo Horie,Junya Masumoto,Su Qiu,(unknown),Yasunori Ogura,Akiko Kawasaki,Koichi Fukase,Shoichi Kusumoto,Miguel A. Valvano,Simon J. Foster,Tak W. Mak,Gabriel Núñez,Naohiro Inohara	1017

About Su Qiu

Su Qiu is a scholar working on Toxicology, Molecular Biology and Immunology, having authored 38 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (19 papers), ATP Synthase and ATPases Research (11 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Immunology (1.3k citations), Toxicology (134 citations) and Microbiology (223 citations). Su Qiu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Shaomeng Wang, Zaneta Nikolovska‐Coleska, Chao‐Yie Yang, Jeanne A. Stuckey, Junya Masumoto, Naohiro Inohara, Gabriel Núñez, Haiying Sun, Yasunori Ogura and Mathias Chamaillard. Their work appears in journals such as Journal of the American Chemical Society, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact